Found 3 hits Enz. Inhib. hit(s) with Target = 'Glucagon receptor' and Ligand = 'BDBM50007232' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007232
(CHEMBL3238222)Show SMILES CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1ccc(F)c(F)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:15.19,6.5,wD:12.13,c:10,(5.5,-43.18,;5.48,-41.64,;4.14,-40.89,;4.15,-42.4,;6.81,-40.86,;6.79,-39.32,;8.11,-38.53,;8.06,-37,;9.27,-36.05,;10.75,-36.46,;8.74,-34.6,;7.19,-34.66,;6.78,-36.14,;5.59,-35.15,;4.14,-35.68,;3.88,-37.2,;5.07,-38.19,;6.52,-37.65,;2.44,-37.73,;1.26,-36.75,;1,-38.27,;2.18,-39.25,;9.51,-33.27,;8.75,-31.93,;9.53,-30.6,;11.07,-30.61,;11.85,-29.28,;11.83,-31.95,;13.37,-31.96,;11.06,-33.28,;9.44,-39.32,;9.42,-40.86,;10.74,-41.65,;12.09,-40.9,;12.11,-39.36,;10.78,-38.57,;13.41,-41.69,;13.39,-43.23,;14.75,-40.93,;16.08,-41.72,;17.42,-40.96,;18.81,-41.6,;19.86,-40.47,;19.1,-39.13,;17.59,-39.43,)| Show InChI InChI=1S/C34H43F2N7O2/c1-32(2,3)16-15-27(21-7-9-22(10-8-21)30(44)37-20-28-39-41-42-40-28)43-31(45)29(23-11-12-25(35)26(36)19-23)38-34(43)17-13-24(14-18-34)33(4,5)6/h7-12,19,24,27H,13-18,20H2,1-6H3,(H,37,44)(H,39,40,41,42)/t24-,27-,34-/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-glucagon from recombinant human GCGR expressed in CHO cells after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Mus musculus) | BDBM50007232
(CHEMBL3238222)Show SMILES CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1ccc(F)c(F)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:15.19,6.5,wD:12.13,c:10,(5.5,-43.18,;5.48,-41.64,;4.14,-40.89,;4.15,-42.4,;6.81,-40.86,;6.79,-39.32,;8.11,-38.53,;8.06,-37,;9.27,-36.05,;10.75,-36.46,;8.74,-34.6,;7.19,-34.66,;6.78,-36.14,;5.59,-35.15,;4.14,-35.68,;3.88,-37.2,;5.07,-38.19,;6.52,-37.65,;2.44,-37.73,;1.26,-36.75,;1,-38.27,;2.18,-39.25,;9.51,-33.27,;8.75,-31.93,;9.53,-30.6,;11.07,-30.61,;11.85,-29.28,;11.83,-31.95,;13.37,-31.96,;11.06,-33.28,;9.44,-39.32,;9.42,-40.86,;10.74,-41.65,;12.09,-40.9,;12.11,-39.36,;10.78,-38.57,;13.41,-41.69,;13.39,-43.23,;14.75,-40.93,;16.08,-41.72,;17.42,-40.96,;18.81,-41.6,;19.86,-40.47,;19.1,-39.13,;17.59,-39.43,)| Show InChI InChI=1S/C34H43F2N7O2/c1-32(2,3)16-15-27(21-7-9-22(10-8-21)30(44)37-20-28-39-41-42-40-28)43-31(45)29(23-11-12-25(35)26(36)19-23)38-34(43)17-13-24(14-18-34)33(4,5)6/h7-12,19,24,27H,13-18,20H2,1-6H3,(H,37,44)(H,39,40,41,42)/t24-,27-,34-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-glucagon from GCGR in mouse liver membranes after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007232
(CHEMBL3238222)Show SMILES CC(C)(C)CC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1ccc(F)c(F)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:15.19,6.5,wD:12.13,c:10,(5.5,-43.18,;5.48,-41.64,;4.14,-40.89,;4.15,-42.4,;6.81,-40.86,;6.79,-39.32,;8.11,-38.53,;8.06,-37,;9.27,-36.05,;10.75,-36.46,;8.74,-34.6,;7.19,-34.66,;6.78,-36.14,;5.59,-35.15,;4.14,-35.68,;3.88,-37.2,;5.07,-38.19,;6.52,-37.65,;2.44,-37.73,;1.26,-36.75,;1,-38.27,;2.18,-39.25,;9.51,-33.27,;8.75,-31.93,;9.53,-30.6,;11.07,-30.61,;11.85,-29.28,;11.83,-31.95,;13.37,-31.96,;11.06,-33.28,;9.44,-39.32,;9.42,-40.86,;10.74,-41.65,;12.09,-40.9,;12.11,-39.36,;10.78,-38.57,;13.41,-41.69,;13.39,-43.23,;14.75,-40.93,;16.08,-41.72,;17.42,-40.96,;18.81,-41.6,;19.86,-40.47,;19.1,-39.13,;17.59,-39.43,)| Show InChI InChI=1S/C34H43F2N7O2/c1-32(2,3)16-15-27(21-7-9-22(10-8-21)30(44)37-20-28-39-41-42-40-28)43-31(45)29(23-11-12-25(35)26(36)19-23)38-34(43)17-13-24(14-18-34)33(4,5)6/h7-12,19,24,27H,13-18,20H2,1-6H3,(H,37,44)(H,39,40,41,42)/t24-,27-,34-/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Antagonist activity at human GCGR expressed in CHO cells assessed as inhibition of glucagon-stimulated cAMP production preincubated for 30 mins follo... |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Search and Browse
